These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 16159402

  • 21. Normal sensitivity to excitotoxicity in a transgenic Huntington's disease rat.
    Winkler C, Gil JM, Araújo IM, Riess O, Skripuletz T, von Hörsten S, Petersén A.
    Brain Res Bull; 2006 Apr 14; 69(3):306-10. PubMed ID: 16564426
    [Abstract] [Full Text] [Related]

  • 22. Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington's disease.
    Bisogno T, Martire A, Petrosino S, Popoli P, Di Marzo V.
    Neurochem Int; 2008 Jan 14; 52(1-2):307-13. PubMed ID: 17664017
    [Abstract] [Full Text] [Related]

  • 23. Opposite effects of the A2A receptor agonist CGS21680 in the striatum of Huntington's disease versus wild-type mice.
    Martire A, Calamandrei G, Felici F, Scattoni ML, Lastoria G, Domenici MR, Tebano MT, Popoli P.
    Neurosci Lett; 2007 Apr 24; 417(1):78-83. PubMed ID: 17331645
    [Abstract] [Full Text] [Related]

  • 24. Metabolic characterization of the R6/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy.
    Tsang TM, Woodman B, McLoughlin GA, Griffin JL, Tabrizi SJ, Bates GP, Holmes E.
    J Proteome Res; 2006 Mar 24; 5(3):483-92. PubMed ID: 16512662
    [Abstract] [Full Text] [Related]

  • 25. Age-dependent biphasic changes in ischemic sensitivity in the striatum of Huntington's disease R6/2 transgenic mice.
    Klapstein GJ, Levine MS.
    J Neurophysiol; 2005 Feb 24; 93(2):758-65. PubMed ID: 15371492
    [Abstract] [Full Text] [Related]

  • 26. Reduction of GnRH and infertility in the R6/2 mouse model of Huntington's disease.
    Papalexi E, Persson A, Björkqvist M, Petersén A, Woodman B, Bates GP, Sundler F, Mulder H, Brundin P, Popovic N.
    Eur J Neurosci; 2005 Sep 24; 22(6):1541-6. PubMed ID: 16190907
    [Abstract] [Full Text] [Related]

  • 27. Microglia density decreases with age in a mouse model of Huntington's disease.
    Ma L, Morton AJ, Nicholson LF.
    Glia; 2003 Sep 24; 43(3):274-80. PubMed ID: 12898706
    [Abstract] [Full Text] [Related]

  • 28. Huntington's disease: the current state of research with peripheral tissues.
    Sassone J, Colciago C, Cislaghi G, Silani V, Ciammola A.
    Exp Neurol; 2009 Oct 24; 219(2):385-97. PubMed ID: 19460373
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Chromosomal instability and supernumerary centrosomes represent precursor defects in a mouse model of T-cell lymphoma.
    van de Wetering CI, Horne MC, Knudson CM.
    Cancer Res; 2007 Sep 01; 67(17):8081-8. PubMed ID: 17804719
    [Abstract] [Full Text] [Related]

  • 32. Modeling brain reserve: experience-dependent neuronal plasticity in healthy and Huntington's disease transgenic mice.
    Nithianantharajah J, Barkus C, Vijiaratnam N, Clement O, Hannan AJ.
    Am J Geriatr Psychiatry; 2009 Mar 01; 17(3):196-209. PubMed ID: 19454847
    [Abstract] [Full Text] [Related]

  • 33. Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease.
    Pang TY, Du X, Zajac MS, Howard ML, Hannan AJ.
    Hum Mol Genet; 2009 Feb 15; 18(4):753-66. PubMed ID: 19008301
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Expression of the Huntington's disease transgene in neural stem cell cultures from R6/2 transgenic mice.
    Chu-LaGraff Q, Kang X, Messer A.
    Brain Res Bull; 2009 Feb 15; 56(3-4):307-12. PubMed ID: 11719265
    [Abstract] [Full Text] [Related]

  • 39. Progressive Cl- channel defects reveal disrupted skeletal muscle maturation in R6/2 Huntington's mice.
    Miranda DR, Wong M, Romer SH, McKee C, Garza-Vasquez G, Medina AC, Bahn V, Steele AD, Talmadge RJ, Voss AA.
    J Gen Physiol; 2017 Jan 15; 149(1):55-74. PubMed ID: 27899419
    [Abstract] [Full Text] [Related]

  • 40. Late onset vascular dysfunction in the R6/1 model of Huntington's disease.
    Rahman A, Ekman M, Shakirova Y, Andersson KE, Mörgelin M, Erjefält JS, Brundin P, Li JY, Swärd K.
    Eur J Pharmacol; 2013 Jan 05; 698(1-3):345-53. PubMed ID: 23117088
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.